Phenergan Articles
FDA pre-emption case: "verdict in 2009"
10 November 2008
Landmark case at US Supreme Court
3 November 2008
FDA labeling rule upsets trial lawyers
1 September 2008
NEJM editors side against Wyeth
1 September 2008
Law suits stall awaiting FDA pre-emption verdict
18 August 2008
SCOTUS signals support for FDA pre-emption
3 March 2008
SCOTUS signals FDA pre-emption support
3 March 2008
FDA pre-emption case taken up by SCOTUS
28 January 2008
Indian Pharma cuts 886 drug prices
13 November 2006
Able gains FDA appro for generic promethazine
12 July 2004
Agis obtains FDA approval for Promethazine
7 July 2003
Baxter acquires ESI in $305M deal
6 January 2003
R-PR's Phenergan Recalled
9 April 1997
Showing 1-16 of 16 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Neovacs moving forward in rheumatoid arthritis, say analysts
